Home
Scholarly Works
Phase II study of oblimersen sodium and rituximab...
Conference

Phase II study of oblimersen sodium and rituximab in patients with recurrent B-cell non-Hodgkin's lymphoma.

Authors

Pro B; Smith MR; Leber B; Younes A; Fayad L; Hagemeister FB; McLaughlin P; Rodriguez AM; Caddick Y; Zwiebel JA

Volume

23

Pagination

pp. 587S-587S

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

June 1, 2005

Name of conference

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Conference place

Orlando, FL

Conference start date

May 13, 2005

Conference end date

May 17, 2005

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

16

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team